Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
A double blinded, balanced, randomized, two-treatment, two-period, two-sequence, single dose, crossover, bioequivalence study comparing Bupropion Hydrochloride Sustained-Release Tablets 150 mg, manufactured for Sun Pharmaceutical Industries Limited, India with PrOdan Bupropion SR (Bupropion Hydrochloride Sustained-Release Tablets 150 mg), product of Odan Laboratories Ltd., 325 Stillview Avenue, Pointe Claire, Quebec, H9R 2Y6, in healthy adult, human subjects under fed condition.
Lacuna Pharma Pty Ltd
major depressive illness
1 trial -
A randomized, two-way, crossover, two parallel groups study to compare the bioavailability of 150 mg and 300 mg trazodone hydrochloride tablets (new polymer) (Angelini Pharma S.p.A.) vs. 150 mg and 300 mg trazodone hydrochloride Contramid® tablets (Angelini Pharma S.p.A.) at steady-state
Lacuna Pharma Pty Ltd
Intended indication: Major Depressive Disorders with and without anxiety, Healthy volunteers, therapeutic indication not studied
1 trial -
A study to assess how radium-223 moves through the patients with prostate cancer receiving radium-223 dichloride treatment.
Bayer AG
Prostate cancer
1 trial -
Amitriptyline Hydrochloride 25Mg Tablet(Hunan Dongting)
The First People's Hospital of Lianyungang
Depressive Disorder
1 trial -
An open label, balanced, randomized, three treatment, three period, three sequence, single dose, crossover study to assess the effect of food and effect of apple sauce on bioavailability of the Test product (Bupropion Hydrochloride Extended Release Capsules 150 mg, manufactured by Sun Pharmaceutical Industries Limited, India) in healthy, adult, human subjects.
Lacuna Pharma Pty Ltd
Seasonal affective disorder, Major depressive disorder
1 trial -
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover, bioavailability study comparing Bupropion Hydrochloride Extended Release Capsules 150 mg, Manufactured by Sun Pharmaceutical Industries Limited, India with WELLBUTRIN XL (Bupropion hydrochloride) extended release tablets 300 mg, Distributed by: Bausch Health US, LLC Bridgewater, NJ 08807 USA. Manufactured by: Bausch Health Companies, Inc. Steinbach, MB R5G 1Z7, Canada, in healthy, adult, human subjects under
Lacuna Pharma Pty Ltd
Seasonal affective disorder, Major depressive disorder
1 trial -
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Naltrexone hydrochloride film-coated tablet, 50 mg, manufactured by Sun Pharmaceutical Industries Limited, India with NALTREXONE GH (naltrexone hydrochloride) film-coated tablets 50 mg, Product of Generic Health Pty Ltd Suite 2, Level 2 19-23 Prospect Street Box Hill, VIC, 3128, Australia, in healthy adult, human subjects under fasting condition.
Lacuna Pharma Pty Ltd
Alcohol dependence
1 trial -
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Ponatinib Tablets 15 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Iclusig (Ponatinib hydrochloride) tablets 15 mg, Produced by: Patheon Inc. Mississauga, Canada or Takeda Ireland Limited Bray, Ireland, Imported and registered by: Pint Pharma Medical-Hospital and Pharmaceutical Products Ltd. Nelson Pontes Street, 125, Block 03, Jardim Margarida Zip Code
Lacuna Pharma Pty Ltd
chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia
1 trial -
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Tamsulosin Hydrochloride Capsules USP 0.4 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Tamsulosin Hydrochloride extended-release capsules 0.4 mg, Product of Geolab Indústria Farmacêutica S/A, VP. 1B QD.08-B Modules 01 to 08, DAIA - Anápolis – GO, in healthy adult, human male subjects under fasting condition.
Lacuna Pharma Pty Ltd
Benign prostatic hyperplasia (BPH)
1 trial -
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Tamsulosin Hydrochloride Capsules USP 0.4 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Tamsulosin Hydrochloride extended-release capsules 0.4 mg, Product of Geolab Indústria Farmacêutica S/A, VP. 1B QD.08-B Modules 01 to 08, DAIA - Anápolis – GO, in healthy adult, human male subjects under fed condition.
Lacuna Pharma Pty Ltd
Benign prostatic hyperplasia (BPH)
1 trial -
Anlotinib hydrochloride,Penpulimab
The First People's Hospital of Lianyungang
Colorectal Cancer
1 trial -
Cocaine hydrochloride
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Induced Sympathoexciation and Vasoconstriction
1 trial -
Dexmethylphenidate Hydrochloride
Teva Pharma GmbH
Healthy
2 trials -
Donepezil Hydrochloride
Teva Pharma GmbH
Healthy
2 trials -
Fexofenadine Hydrochloride without sodium lauryl sulfate
BRIGHT MINDS BIOSCIENCES INC.
The Impact of Excipients on Drug Absorption
1 trial -
Fluoxetine Hydrochloride
Teva Pharma GmbH
Healthy
2 trials -
Granisetron hydrochloride 1 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Liposomal Mitoxantrone Hydrochloride dose level 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non Hodgkin Lymphoma
1 trial -
Lofexidine hydrochloride
BRIGHT MINDS BIOSCIENCES INC.
Normal Healthy Volunteers
1 trial -
Lofexidine hydrochloride
BRIGHT MINDS BIOSCIENCES INC.
Normal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the Product
1 trial -
Midazolam hydrochloride
CORCEPT THERAPEUTICS INC
Healthy
1 trial -
Naloxone Hydrochloride
BRIGHT MINDS BIOSCIENCES INC.
Opioid-use Disorder
1 trial -
Open label, single-center, cross-over randomized, relative bioavailability study comparing a new pitolisant hydrochloride tablet formulation versus the marketed pitolisant (Wakix®) tablet formulation after single oral administrations in healthy subjects.
Bioprojet Pharma
narcolepsy with cataplexy, Narcolepsy
1 trial -
Open label, single-center, cross-over randomized, relative bioavailability study comparing a new pitolisant hydrochloride tablet formulation at 4 different strengths versus the marketed pitolisant (Wakix®) tablet formulation after single oral administrations in healthy subjects
Bioprojet Pharma
Narcolepsy, Narcolepsy with cataplexy
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources